Annual EBITDA
$3.43B$48.00M+1.42%
Summary
- Current Value
- As of today, IQV annual EBITDA is $3.43B, up +1.42% on
- Historical Performance
- IQV annual EBITDA is up +15.64% over the past 3 years, up +65.83% over the past 5 years
- All-Time High Comparison
- IQV annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- IQV annual EBITDA is +15.64% above its 3-year low of $2.97B reached on an earlier date
- Sector Comparison
- IQV annual EBITDA is higher than 96.99% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.43B | +1.4% | +15.6% | +65.8% | +579.4% | |
| Quarterly EBITDA | $861.00M | +8.7% | +18.9% | +28.1% | – | |
| TTM EBITDA | $3.49B | +3.2% | +19.1% | +57.7% | – | |
| Price | $167.90 | +21.6% | -16.8% | -29.7% | – | |
| PE Ratio | 20.81 | +10.6% | -42.6% | -81.8% | – | |
| Annual Revenue | $16.30B | +5.8% | +13.1% | +43.5% | +315.5% | |
| Annual EPS | $7.84 | +4.7% | +36.9% | +447.9% | +529.2% | |
| $2.29B | +0.8% | +24.5% | +192.5% | +443.5% | ||
| Annual Net Income | $1.36B | -0.9% | +24.8% | +341.9% | +723.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.43B | at high | |
| 5Y | $3.43B | at high | |
| All | $3.43B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.97B | N/A | +15.6% |
| 5Y | $2.07B | N/A | +65.8% |
| All | $473.57M | +624.5% |
EBITDA History
FAQ
What is the current annual EBITDA of IQV?
As of today, IQV annual EBITDA is $3.43B
What is 1-year change in IQV annual EBITDA?
IQV annual EBITDA is up +1.42% year-over-year
What is 3-year change in IQV annual EBITDA?
IQV annual EBITDA is up +15.64% over the past 3 years
How far is IQV annual EBITDA from its all-time high?
IQV annual EBITDA is currently at its all-time high
How does IQV annual EBITDA rank versus sector peers?
IQV annual EBITDA is higher than 96.99% of companies in Healthcare sector
When is IQV next annual earnings release?
As of today, the next annual earnings release for IQV has not been scheduled
Quarterly EBITDA
$861.00M$102.00M-10.59%
Summary
- Current Value
- As of today, IQV quarterly EBITDA is $861.00M, down -10.59% on
- Historical Performance
- IQV quarterly EBITDA is up +8.71% year-over-year, up +18.92% over the past 3 years
- All-Time High Comparison
- IQV quarterly EBITDA is currently -10.59% below its historical high of $963.00M set on
- 3-Year Low Comparison
- IQV quarterly EBITDA is +18.92% above its 3-year low of $724.00M reached on an earlier date
- Sector Comparison
- IQV quarterly EBITDA is higher than 96.49% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $861.00M | -10.6% | +8.7% | +18.9% | +28.1% | |
| Annual EBITDA | $3.43B | – | +1.4% | +15.6% | +65.8% | |
| TTM EBITDA | $3.49B | +2.0% | +3.2% | +19.1% | +57.7% | |
| Price | $167.90 | +1.4% | +21.6% | -16.8% | -29.7% | |
| PE Ratio | 20.81 | -1.3% | +10.6% | -42.6% | -81.8% | |
| Quarterly Revenue | $4.16B | -4.6% | +8.6% | +14.4% | +22.1% | |
| Quarterly EPS | $1.61 | -46.0% | +15.0% | +5.3% | +48.4% | |
| $328.00M | -49.2% | -37.8% | -30.4% | -6.0% | ||
| Quarterly Net Income | $275.00M | -46.5% | +10.4% | -4.8% | +26.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $963.00M | -10.6% | |
| 3Y | $963.00M | -10.6% | |
| 5Y | $963.00M | -10.6% | |
| All | $963.00M | -10.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $792.00M | N/A | +8.7% |
| 3Y | $724.00M | N/A | +18.9% |
| 5Y | $631.00M | +36.5% | |
| All | $118.10M | +629.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of IQV?
As of today, IQV quarterly EBITDA is $861.00M
What is IQV quarterly EBITDA most recent change?
IQV quarterly EBITDA was down -10.59% on March 31, 2026
What is 1-year change in IQV quarterly EBITDA?
IQV quarterly EBITDA is up +8.71% year-over-year
How far is IQV quarterly EBITDA from its all-time high?
IQV quarterly EBITDA is currently -10.59% below its historical high of $963.00M set on December 31, 2025
How does IQV quarterly EBITDA rank versus sector peers?
IQV quarterly EBITDA is higher than 96.49% of companies in Healthcare sector
When is IQV next earnings release?
The next earnings release for IQV is on
TTM EBITDA
$3.49B$69.00M+2.01%
Summary
- Current Value
- As of today, IQV TTM EBITDA is $3.49B, up +2.01% on
- Historical Performance
- IQV TTM EBITDA is up +3.16% year-over-year, up +19.05% over the past 3 years
- All-Time High Comparison
- IQV TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- IQV TTM EBITDA is +19.05% above its 3-year low of $2.94B reached on an earlier date
- Sector Comparison
- IQV TTM EBITDA is higher than 96.49% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $3.49B | +2.0% | +3.2% | +19.1% | +57.7% | |
| Annual EBITDA | $3.43B | – | +1.4% | +15.6% | +65.8% | |
| Quarterly EBITDA | $861.00M | -10.6% | +8.7% | +18.9% | +28.1% | |
| Price | $167.90 | +1.4% | +21.6% | -16.8% | -29.7% | |
| PE Ratio | 20.81 | -1.3% | +10.6% | -42.6% | -81.8% | |
| TTM Revenue | $16.63B | +2.0% | +7.3% | +14.8% | +38.5% | |
| TTM EPS | $8.07 | +2.7% | +9.9% | +44.8% | +284.9% | |
| $2.08B | -8.7% | -8.4% | +15.2% | +125.8% | ||
| TTM Net Income | $1.39B | +1.9% | +4.0% | +31.5% | +219.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.49B | at high | |
| 3Y | $3.49B | at high | |
| 5Y | $3.49B | at high | |
| All | $3.49B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.38B | +3.3% | |
| 3Y | $2.94B | N/A | +19.1% |
| 5Y | $2.22B | N/A | +57.7% |
| All | $118.10M | +2858.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of IQV?
As of today, IQV TTM EBITDA is $3.49B
What is IQV TTM EBITDA most recent change?
IQV TTM EBITDA was up +2.01% on March 31, 2026
What is 1-year change in IQV TTM EBITDA?
IQV TTM EBITDA is up +3.16% year-over-year
How far is IQV TTM EBITDA from its all-time high?
IQV TTM EBITDA is currently at its all-time high
How does IQV TTM EBITDA rank versus sector peers?
IQV TTM EBITDA is higher than 96.49% of companies in Healthcare sector
When is IQV next earnings release?
The next earnings release for IQV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- IQV Official Website www.iqvia.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1478242/000119312525312900/0001193125-25-312900-index.htm
- IQV Profile on Yahoo Finance finance.yahoo.com/quote/IQV
- IQV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iqv